Verastem Inc. (VSTM) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.35, Verastem Inc. dropped to $1.24 for a new 52-week low. By the closing bell, the company's stock was at $1.32 a share for a loss of 5.71%.
Falling to a new 52-week low is never fun for company's shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.
However one plays it, it's often a critical moment for any stock and should be noted by investors.
Verastem Inc. saw 257,224 shares of its stock trade hands, that's out of 36.93 million shares outstand. The stock has an average daily volume of 812,335 shares. After hitting a new 52-week low, Verastem Inc. enters the new trading day with a market cap of 48.75 million, a 50-day SMA of $1.92 and a 200-day SMA of $5.59
For a complete fundamental analysis analysis of Verastem Inc., check out Equities.com’s Stock Valuation Analysis report for VSTM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
Verastem Inc is a biopharmaceutical company engaged in discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics.
Verastem Inc. has 20 employees, is led by CEO Robert Forrester, and makes its home in Needham, MA.
Verastem Inc. is also a component of the Russell 2000 Index, which is generally viewed as the most reliable indicator of the health of the broader small-cap market. Using a rules-based methodology, it creates a simple, unbiased view of how America's stable of smaller publicly traded companies are performing in the stock markets.
The index consists of the 2,000 smallest companies of the 3,000 largest publicly-traded companies in the country as judged by market cap. It's constructed by Russell Investments, which also builds and maintains the Russell 3000 (an index consisting of all 3,000 biggest companies by market cap) and the large-cap Russell 1000 (which has the 1,000 largest companies from the Russell 3000).
All data provided by QuoteMedia and was accurate as of 4:30PM ET.